Product Highlight - Esmya

27 Sep 2019
Product Highlight - Esmya

Active ingredient: Ulipristal acetate

Indications:

  • One treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
  • Intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age who are not eligible for surgery.

Dosage & Administration: The treatment consists of one tablet of 5 mg to be taken once daily for treatment courses of up to 3 months each. Tablets may be taken with or without food.

Presentation: Tab 5 mg x 28’s.


ZUELLIG PHARMA LTD
8-9 Fl, Ploenchit Center 2 Sukhumvit Rd Kwaeng Klongtoey Khet Klongtoey Bangkok 10110
• Tel: (+66) 2656 9800 • Fax: (+66) 2342 3433